Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease

BACKGROUND: Small vessel disease causes a quarter of ischaemic strokes (lacunar subtype), up to 45% of dementia either as vascular or mixed types, cognitive impairment and physical frailty. However, there is no specific treatment to prevent progression of small vessel disease. AIM: We designed the L...

Descripción completa

Detalles Bibliográficos
Autores principales: Wardlaw, Joanna, Bath, Philip M W, Doubal, Fergus, Heye, Anna, Sprigg, Nikola, Woodhouse, Lisa J, Blair, Gordon, Appleton, Jason, Cvoro, Vera, England, Timothy, Hassan, Ahamad, John Werring, David, Montgomery, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538764/
https://www.ncbi.nlm.nih.gov/pubmed/33072884
http://dx.doi.org/10.1177/2396987320920110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538764/
https://www.ncbi.nlm.nih.gov/pubmed/33072884
http://dx.doi.org/10.1177/2396987320920110

Ejemplares similares